Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.
Journal: Nature aging
Published: June 30, 2025
DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia: Clinical Insights from a Real-World Early Experience Program.
Journal: Movement disorders clinical practice
Published: May 07, 2025
Efficacy and safety of DaxibotulinumtoxinA for injection in adults with cervical dystonia: Pooled global analysis of ASPEN-1 and ASPEN-1-CN randomized trials.
Journal: Parkinsonism & related disorders
Published: March 14, 2025
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA.
Journal: Toxins
Published: January 24, 2025
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study.
Journal: Parkinsonism & related disorders
Published: September 26, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information.
Journal: Toxins
Published: August 19, 2024
Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label Study.
Journal: Movement disorders clinical practice
Published: July 11, 2024
A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.
Journal: Journal of Parkinson's disease
Published: January 22, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Journal: Brain : a journal of neurology
Published: December 12, 2023
Last Updated: 09/26/2026